Create events, manage exams and configure the device
Download the app from the stores:
Continuous cardiac monitoring for better identification of arrhythmias
Extending the days of cardiac monitoring increases the percentage of arrhythmia identification, as a study shows.
24 hours - less than 50%
4 days - around 80%
7 days - over 85%
We have solved the problem of the diagnostic gap in cardiac arrhythmias
QuoreOne provides continuous monitoring for up to 7 days, improving the diagnostic rate of atrial fibrillation and allowing for more appropriate treatment of the patient.
REFERENCES ON THIS PAGE
REFERENCES ON THIS PAGE
1- M. Yenikomshian et al, Cardiac Arrhythmia Detection Monitored with Patch System, Current Medical Research and Opinion, 209, vol 35, no. 10, 1659-1670
2 - J.L. Clua-Espuny et al. Prevalence of Undiagnosed Atrial Fibrillation and of That Not Being Treated With Anticoagulant Drugs: the AFABE Study , Rev Esp Cardiol. 2013;66(7):545–552
3- Parikh P, et al, Diagnostic Yield of 24-Hour Holter vs 7-Day and 14-Day ePatch Extended Wear Holter, American College Cardiology.2023/ World Health Federation Annual Scientific Section, New Orleans, March 2023
4 -Ul-Qamar M.J., et al, Arrhythmias and sudden death Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all- comer patient cohort and association with clinical and Holter variables, Open Heart 2020;7:e001151. doi:10.1136/openhrt-2019-001151
5- Gladstone D. J, et al, Screening for Atrial Fibrillation in the Older Population, JAMA Cardiol. 2021 May; 6(5): 1–10.